| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/02/1996 | US5504205 Reduced sp3 texaphyrins |
| 03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | WO1996009325A1 Modified radioantibody fragments for reduced renal uptake |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009075A1 Method of treating malignant conditions |
| 03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
| 03/27/1996 | EP0702685A1 Texaphyrin metal complex mediated ester hydrolysis |
| 03/27/1996 | EP0702570A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
| 03/27/1996 | EP0702569A1 Liver function breath test using aromatic amino acids |
| 03/27/1996 | CN1119415A Substance for detecting amyloid deposition |
| 03/26/1996 | CA1338187C Halogen labeled compounds including estradiol derivatives, synthetic intermediates, syntheses thereof and uses thereof |
| 03/21/1996 | WO1996008565A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 03/21/1996 | WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | WO1996008236A1 Capsules with internal waterproof coating for containing matrix-adsorbed aqueous (radioactive) solutions and method of preparing said capsules |
| 03/21/1996 | CA2200097A1 Recombinant peptides derived from the mc3 anti-ba46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| 03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 03/20/1996 | EP0701457A1 Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
| 03/20/1996 | EP0701435A1 Compositions for boron neutron capture therapy and methods thereof |
| 03/20/1996 | CN1118696A Emulsive contrast medium and its preparing method |
| 03/14/1996 | WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 03/14/1996 | WO1996007435A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | DE4432557A1 Kapseln mit innenseitig hydrophober Beschichtung zur Aufnahme von matrixadsorbierten wäßrigen (radioaktiven) Lösungen und Verfahren zur Herstellung obiger Kapseln Capsules having a hydrophobic coating on the inside for receiving matrixadsorbierten aqueous (radioactive) solutions and methods for preparing the above capsules |
| 03/13/1996 | EP0700930A1 Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
| 03/13/1996 | EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 03/13/1996 | EP0560910B1 Molecular sieve-enclosed paramagnetic ion for diagnosis |
| 03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
| 03/13/1996 | EP0438497B1 Vasopermeability-enhancing conjugates |
| 03/13/1996 | CN1031242C 化妆品组合物 Cosmetic composition |
| 03/12/1996 | US5498618 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides for treating smooth muscle contraction disorders |
| 03/12/1996 | US5498421 Composition useful for in vivo delivery of biologics and methods employing same |
| 03/12/1996 | US5497763 To the lungs |
| 03/07/1996 | WO1996000087A3 Kit for pretargeting and novel pretargeting conjugates |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
| 03/06/1996 | EP0515638B1 Novel preorganized hexadentate ligands useful in radiographic imaging agents |
| 03/06/1996 | EP0416033B1 Macrocyclic chelates and methods of use thereof |
| 03/06/1996 | CN1118136A Methods for in vivo delivery of biologics and compositions useful therefor |
| 03/05/1996 | US5496953 Dopamine transporter sites, radioactive, diagnosis, imaging, nortropane derivatives |
| 03/05/1996 | US5496929 Radiopharmaceutical product having in particular a cerebral tropism comprising a nitruro complex of a transition metal and method for preparing said product |
| 03/05/1996 | US5496705 Monoclonal antibody specific for rat synaptophysin |
| 03/05/1996 | US5496533 Rhenium complexes |
| 02/29/1996 | WO1996005818A1 Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases |
| 02/28/1996 | EP0697894A1 Dopamine d-3 and serotonin (5-ht 1a?) receptor ligands and imaging agents |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697884A1 Ligand precursors for incorporation into peptides |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/28/1996 | CN1117713A Gas mixtures useful as ultrasound contrast media |
| 02/27/1996 | US5494895 Scorpion peptide margatoxin with immunosuppressant activity |
| 02/27/1996 | US5494791 Monoclonal antibodies against glycated low density lipoprotein |
| 02/27/1996 | US5494682 Encapsulated biomass in crosslinked polymer material |
| 02/27/1996 | US5494654 Radiolabelled compound formulations |
| 02/22/1996 | WO1996005209A2 Sialic acid/fucose based medicaments |
| 02/22/1996 | WO1996005167A1 Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
| 02/22/1996 | WO1996004922A1 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| 02/22/1996 | DE4428874A1 Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel Dimeric DTPA derivatives and their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics and therapy and methods for preparing the complexes and agents |
| 02/22/1996 | CA2197336A1 Sialic acid/fucose based medicaments |
| 02/22/1996 | CA2197074A1 Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
| 02/22/1996 | CA2196408A1 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| 02/21/1996 | EP0696906A1 Vascular implant |
| 02/20/1996 | US5493026 Labeled with radioactive isotopes for tomography |
| 02/20/1996 | US5493017 Ring-metalated porphyrins |
| 02/20/1996 | US5492924 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 02/20/1996 | CA1338072C Conjugates for bone imaging and bone cancer therapy |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004308A1 Cyclic hexapeptide somatostatin analogues |
| 02/15/1996 | WO1996004302A1 Novel tumor marker for lung cancer |
| 02/15/1996 | WO1996004015A1 Microparticle preparations for clearing blood-dissolved substances |
| 02/15/1996 | WO1996003875A1 Compositions for targeting materials to cells containing androgen receptors |
| 02/15/1996 | CA2197770A1 Compositions for targeting materials to cells containing androgen receptors |
| 02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 02/14/1996 | EP0696207A1 Use of cyclopentadienylcarbonyl transition metal carboxylic acids and their derivatives for labelling proteins |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/08/1996 | WO1996003646A1 Chelator idac-2 and method for purifying chelator conjugated compounds |
| 02/08/1996 | WO1996003429A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | WO1996003427A1 Peptide derived radionuclide chelators |
| 02/08/1996 | WO1996003112A1 Compositions comprising a tissue glue and therapeutic agents |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4428056A1 Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut Use of microparticle preparations for eliminating the dissolved, non-renal common substances from the blood |
| 02/08/1996 | CA2195525A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | CA2194551A1 Peptide derived radionuclide chelators |
| 02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
| 02/07/1996 | EP0695194A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/06/1996 | USRE35152 Administering detectably labeled immunoglobulin that accumulates at inflammation site |
| 02/06/1996 | US5489668 Immunoassay reagents and method for determining cyclosporine |
| 02/06/1996 | US5489425 Functionalized polyamine chelants |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/03/1996 | CA2154983A1 Radiolabelled angiotensin converting enzyme inhibitors |
| 02/01/1996 | WO1996002568A1 Complexes for use in the diagnosis of vascular diseases |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002500A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2194561A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |